Literature DB >> 30247213

Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy?

Amanda Ying Wang1,2, Rinaldo Bellomo3.   

Abstract

PURPOSE OF REVIEW: Severe acute kidney injury in the ICU setting often requires renal replacement therapy (RRT). Intermittent hemodialysis (IHD), hybrid forms of RRT such as sustained low-efficiency dialysis (SLED), as well as continuous renal replacement therapy (CRRT) are the three common modalities of extracorporeal RRT used in the adult ICU setting in developed countries. This review summarizes recently published data regarding comparisons of these three RRT modalities on clinical outcomes (e.g., mortality and recovery of renal function) in severe acute kidney injury (AKI) patients. RECENT
FINDINGS: There is still controversy on the superiority of one RRT modality over another in terms of clinical outcomes in patients with AKI in ICU. Although there is increasing acceptance that CRRT should be used in hemodynamic unstable patients, its survival advantages over IHD remains unproven because of inadequate evidence from suitably powered randomized controlled trials (RCTs). Moreover, CRRT does not show superiority to intermittent renal replacement therapy (IRRT) in hemodynamic stable patients. Although patients receiving sustained low-efficiency dialysis appear to have lower mortality than CRRT, its survival benefit is largely derived from observational studies and is confounded by selection bias. Current literature supports no differences in mortality among the three RRT modalities. However, the effect of choice of RRT modality on short-term and long-term renal outcomes need further studies, especially larger RCTs and longer duration of follow-up.
SUMMARY: There is lack of solid evidence showing superiority of any mode of RRT in patients with severe AKI in terms of patient survival. However, based on observational data, IHD treatment of AKI may delay renal recovery. Patients' hemodynamic status, coexisting medical conditions, local expertise, and availability of staff and resources as well as potential effect on long-term renal outcomes should be taken into consideration when selecting modalities of RRT for adult ICU patients.

Entities:  

Mesh:

Year:  2018        PMID: 30247213     DOI: 10.1097/MCC.0000000000000541

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

Review 1.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

Review 2.  Single-best Choice Between Intermittent Versus Continuous Renal Replacement Therapy: A Review.

Authors:  Nida Fathima; Tooba Kashif; Rajesh Naidu Janapala; Joseph S Jayaraj; Aisha Qaseem
Journal:  Cureus       Date:  2019-09-03

3.  Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Hiraku Tsujimoto; Yasushi Tsujimoto; Yukihiko Nakata; Tomoko Fujii; Sei Takahashi; Mai Akazawa; Yuki Kataoka
Journal:  Cochrane Database Syst Rev       Date:  2020-03-13

4.  Evaluation on treatment of sustained low-efficiency hemodialysis against patients with multiple organ dysfunction syndrome following wasp stings.

Authors:  Ting-Ting Ye; Rong Gou; Ya-Ni Mao; Jian-Ming Shen; Dong He; Yan-Yan Deng
Journal:  BMC Nephrol       Date:  2019-07-03       Impact factor: 2.388

5.  Hypothermia related to continuous renal replacement therapy: incidence and associated factors.

Authors:  Cássia Maria Frediani Morsch; Jaqueline Sangiogo Haas; Rose Plotnick; Taciana de Castilhos Cavalcanti; Patrícia Cristina Cardoso; Tatiana Pilger; Juliana Teixeira da Silveira; Fernando Saldanha Thomé
Journal:  Rev Bras Ter Intensiva       Date:  2021 Jan-Mar

6.  Levetiracetam poisoning with acute kidney injury treated with hemodialysis: A case report.

Authors:  Hiraku Sedogawa; Norihiro Watanabe; Yoshikazu Hirose; Naoko Mizouchi; Shunri Shimagaki; Hiroki Yamaguchi; Yasuo Hirose
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

7.  Early Effects of Extracellular Vesicles Secreted by Adipose Tissue Mesenchymal Cells in Renal Ischemia Followed by Reperfusion: Mechanisms Rely on a Decrease in Mitochondrial Anion Superoxide Production.

Authors:  Jarlene A Lopes; Federica Collino; Clara Rodrigues-Ferreira; Luzia da Silva Sampaio; Glória Costa-Sarmento; Camila H C Wendt; Fernando P Almeida; Kildare R Miranda; Tais H Kasai-Brunswick; Rafael S Lindoso; Adalberto Vieyra
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.